Cancellation of state registration. Corvitol® 50

January 16, 2018

Active substances:

Metoprolol

Trade names:

Corvitol® 50

ICD-10:

V.F40-F48.F45.3 Somatoform dysfunction of the autonomic nervous system

VI.G40-G47.G43 Migraine

IX.I10-I15.I10 Essential [primary] hypertension

IX.I20-I25.I20 Angina pectoris [angina pectoris]

IX.I20-I25.I21 Acute myocardial infarction

IX.I30-I52.I47.1 Nadzheludochkovaya tachycardia

IX.I30-I52.I49.4 Other and unspecified depolarization

Corvitol 50, metoprolol, heart rhythm disturbances, extrasystole, treatment of arterial hypertension, supraventricular tachycardia, hyperkinetic cardiac syndrome, prevention of angina attacks, IHD, prevention of migraine attacks, migraine

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicinal products", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N012267 / 01 from 26.07.2010 issued by Berlin-Chemie AG, Germany):

Corvitol® 50 (trade name of the medicinal product)

Metoprolol (international non-proprietary or grouping or chemical name)

tablets, 50 mg (dosage form, dosage)

Berlin-Chemie AG, Germany Glienicker Weg 125, 12489, Berlin, Germany (name and address of the location of the manufacturer of the medicinal product)

on the basis of an application by the authorized legal entity LLC Berlin-Chemie / A. Menarini to cancel the state registration of the medicinal product.